Stay updated on AK104+Platinum±Bevacizumab Clinical Trial
Sign up to get notified when there's something new on the AK104+Platinum±Bevacizumab Clinical Trial page.

Latest updates to the AK104+Platinum±Bevacizumab Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 4, 2025.SummaryDifference0.7%
- Check82 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the date from '2022-04-27' to '2025-03-04'.SummaryDifference1%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to AK104+Platinum±Bevacizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104+Platinum±Bevacizumab Clinical Trial page.